FINAL REVIEW
LIVER ANATOMY AND PHYSIOLOGY
Anatomical Boundaries and Compartments:
Glisson Capsule: Fibrous capsule enclosing the entirety of the liver.
Bare Area: Portion of the liver directly touching the diaphragm that is not covered by Glisson capsule.
Morison's Pouch (Hepatorenal Recess): A gravity-dependent potential space located between the right lobe of the liver and the right kidney; it serves as a primary site for free fluid collection.
Porta Hepatis: Known as the liver hilum, marking the specific site where blood vessels enter and the Common Bile Duct (CBD) exits.
Portal Triad: Visualized classic cross-section ("Mickey Mouse" sign) comprising the main portal vein, hepatic artery, and common bile duct.
Dividing Anatomical Landmarks:
Right and Left Lobe Separation: Main Lobar Fissure (MLF), Middle Hepatic Vein (MHV), and Gallbladder (GB) fossa.
Left Lobe Segments Separation (Medial vs. Lateral): Left Hepatic Vein (LHV) superiorly, umbilical segment of the Left Portal Vein (LPV), and Ligamentum Teres inferiorly.
Caudate Lobe (Segment 1) Boundaries: Separated from the right lobe by the Inferior Vena Cava (IVC), from the left lobe by the Ligamentum Venosum, and from Segment 4 by the horizontal segment of the LPV.
Segment 7 and 8 Division: Right Hepatic Vein (RHV).
Vascular Course: Right Portal Vein (RPV) runs intrasegmentally within the right lobe, whereas Hepatic Veins (HVs) course intersegmentally.
Couinaud Segmental Anatomy:
Segment 1: Caudate lobe (located superiorly and posteriorly).
Segment 2: Lateral segment of the left lobe (superior).
Segment 3: Lateral segment of the left lobe (inferior).
Segment 4: Quadrate lobe / medial segment of the left lobe.
Segment 5: Inferior/anterior segment of the right lobe.
Segment 6: Inferior/posterior segment of the right lobe.
Segment 7: Superior/posterior segment of the right lobe.
Segment 8: Superior/anterior segment of the right lobe.
Hepatic Ligaments:
Ligamentum Teres: Remnant of the obliterated umbilical vein; divides the left lobe into medial and lateral segments.
Ligamentum Venosum: Remnant of the ductus venosus; separates the caudate lobe from the left lobe.
Falciform Ligament: Connects the anterior liver surface to the anterior abdominal wall; readily visualized when ascites is present.
Normal Anatomical Variants:
Riedel's Lobe: An inferior tongue-like projection of the right lobe extending past the lower pole of the right kidney.
Papillary Process: Inferior and medial projection of the caudate lobe; must be evaluated carefully to prevent misidentification as an enlarged lymph node.
Hepatic Vascular Hemodynamics:
Hepatic Artery: Supplies of total blood flow into the liver; carries oxygenated blood; exhibits hepatopetal flow with a low Resistive Index (RI) that increases postprandially (leading to decreased overall flow).
Portal Vein: Supplies of total blood flow into the liver; delivers nutrient-rich blood from the intestines and spleen; hepatopetal flow; demonstrates respiratory phasicity under normal physiological conditions.
Hepatic Veins (RHV, MHV, LHV): Drain blood away from the liver directly into the IVC; hepatofugal flow; exhibits increased flow following food intake; displays a pulsatile triphasic waveform due to anatomical proximity to the heart (reflecting right atrial contraction, systole, and diastole).
Hepatic Physiology and Metabolic Functions:
Bile Formation and Bilirubin Processing: Breakdown of red blood cells generates unconjugated bilirubin, which binds to albumin for delivery to the liver. Hepatocytes conjugate bilirubin, enabling its excretion into bile. Bile salts, synthesized from cholesterol, emulsify fats to assist in fatty acid absorption.
Carbohydrate Metabolism: Maintains blood glucose levels through glycogenesis and glycogenolysis.
Fat Metabolism: Converts excess lipids and cholesterol into bile salts.
Protein Synthesis: Produces essential plasma proteins including albumin, prothrombin, and fibrinogen.
Detoxification: Converts toxic metabolic ammonia into urea for renal excretion.
LIVER FUNCTION TESTS (LFTS)
Aspartate Aminotransferase (AST):
Non-specific to the liver; also synthesized in cardiac and skeletal muscle tissues.
Serum elevation indicates acute cellular injury (e.g., acute hepatitis, active cirrhosis).
Markedly higher in cirrhosis and metastatic carcinoma.
Alanine Aminotransferase (ALT):
Highly specific to liver tissue.
Serum elevation signifies hepatocyte destruction or biliary tract obstruction.
Higher elevation relative to AST is seen in acute hepatitis, alcoholic liver disease, and hepatic obstruction.
Bilirubin Fractions:
Indirect (Unconjugated) Bilirubin: Elevates with accelerated red blood cell destruction (e.g., hemolytic anemia).
Direct (Conjugated) Bilirubin: Elevates secondary to direct biliary tract obstruction.
Combined Elevation (Direct > Indirect): Associated with hepatic metastasis, hepatitis, lymphoma, cholestasis, and cirrhosis.
Alkaline Phosphatase (ALP / Alk Phos):
Enzyme synthesized in liver tissue, bone, and placenta; excreted via the biliary system.
Serum levels increase significantly during biliary obstruction and viral hepatitis.
Alpha-Fetoprotein (AFP):
Fetal serum protein produced by the yolk sac and fetal liver.
Re-emergence in adult serum indicates primary liver malignancies (Hepatocellular Carcinoma and Hepatoblastoma) as well as non-seminomatous testicular or ovarian germ cell tumors.
Albumin and Globulins:
Albumin: Main constituent of total serum protein synthesized exclusively by hepatocytes; maintains oncotic pressure and acts as a transport protein for unconjugated bilirubin.
Hypoalbuminemia: Decreased serum albumin leads to diminished oncotic pressure, producing peripheral edema and abdominal ascites; indicates chronic parenchymal disease and cirrhosis.
A/G Ratio: Albumin to Globulin ratio altered specifically in chronic liver states such as cirrhosis.
Additional Serum Markers: Lactate Dehydrogenase (LDH), Prothrombin Time (PT - evaluates clotting factor production), and Gamma-Glutamyl Transferase (GGT).
DIFFUSE AND FOCAL LIVER PATHOLOGY
Fatty Liver (Hepatic Steatosis):
Intra-cytoplasmic lipid accumulation inside hepatocytes.
Etiologies: Alcohol consumption, metabolic conditions (glycogen storage diseases), systemic hypertension, diabetes mellitus, obesity, dyslipidemia/hypercholesterolemia, viral hepatitis, Total Parenteral Nutrition (TPN), pregnancy, cystic fibrosis.
Sonographic Grading:
Mild: Increased parenchymal echogenicity relative to the renal cortex.
Moderate: Diffusely increased echogenicity with impaired visualization of intrahepatic portal vein walls.
Severe: Marked increase in echogenicity (renal cortex appears dark), complete loss of portal vein wall echogenicity, and poor visualization of the diaphragm due to acoustic attenuation.
Focal Fatty Infiltration: Localized areas of lipid accumulation appearing as echogenic regions with geometric/geographical borders. Typically situated in Segment 4, anterior to the portal vein bifurcation and adjacent to the gallbladder fossa. Does not mass-effect or displace vascular structures; displays iso-enhancement on Contrast-Enhanced Ultrasound (CEUS).
Focal Fatty Sparing: Localized regions spared from lipid deposition within a diffusely fatty liver. Appears hypoechoic with geometric borders, retaining the same predilection sites as focal infiltration.
Glycogen Storage Disease Type I (Von Gierke Disease):
Autosomal recessive metabolic disorder characterized by excessive glycogen deposition in hepatic tissue.
Direct association with a significantly heightened incidence of hepatic adenomas.
Cirrhosis:
Irreversible, end-stage process characterized by diffuse fibrosis, parenchymal necrosis, scarring, and nodular hepatocyte regeneration.
Etiologies: Chronic alcoholism, chronic viral hepatitis, metabolic dysfunction-associated steatohepatitis (MASH), Primary Sclerosing Cholangitis (PSC), primary and secondary biliary cirrhosis, glycogen storage diseases, Wilson disease (pathologic copper accumulation), and Hemochromatosis (pathologic iron accumulation).
Clinical Presentation: Hepatomegaly (early), jaundice, persistent ascites, portal hypertension, elevated serum LFTs, and markedly increased risk of Hepatocellular Carcinoma (HCC).
Sonographic Findings:
Early Stage: Hepatomegaly with initial coarse parenchymal texture.
Late Stage: Small, atrophic liver with surface nodularity, caudate lobe hypertrophy, narrowing of hepatic veins, potential compression of the IVC, and gross ascites.
Vascular & Doppler Features: Features of portal hypertension (decreased portal vein phasicity, eventual flow reversal), and signs of Budd-Chiari syndrome (aliasing in hepatic veins with loss of triphasic pulsatility).
Portal Hypertension:
Abnormally elevated blood pressure within the portal venous system.
Classification of Causes:
Pre-hepatic: Main portal vein thrombosis or extrinsic tumor compression (e.g., pancreatic head adenocarcinoma).
Intrahepatic: Hepatic cirrhosis (most common cause in Western countries).
Post-hepatic: Budd-Chiari syndrome, IVC thrombosis, right-sided congestive heart failure.
Sonographic & Doppler Findings: Main Portal Vein diameter , reduced mean flow velocity in the portal vein with compensatory increase in hepatic artery flow velocity, progressive loss of respiratory phasicity leading to biphasic ("to-and-fro") flow, eventual hepatofugal flow, development of portosystemic collateral pathways (varices), splenomegaly, and ascites.
Interventional Management: Transjugular Intrahepatic Portosystemic Shunt (TIPSS) placed to decompress the portal system by creating an intrahepatic conduit between a portal vein branch and a hepatic vein branch (typically RPV to RHV).
Budd-Chiari Syndrome:
Occlusion or symptomatic obstruction of hepatofugal venous outflow at the level of the hepatic veins or the hepatic segment of the IVC.
Congestive Hepatopathy:
Passive hepatic congestion resulting from right-sided heart failure. Leads to marked enlargement and dilatation of the IVC and hepatic veins, along with highly pulsatile flow patterns in both hepatic and portal veins.
LIVER INFECTIONS AND INFLAMMATORY CONDITIONS
Viral Hepatitis:
Acute or chronic inflammation of the hepatic parenchyma driven by viral pathogens, toxins, or autoimmune processes.
Viral Transmission Routes:
Hepatitis A & E: Fecal-oral route.
Hepatitis B (HBV): Parenteral exposure, blood transfusions, contaminated needle punctures (preventable via vaccine).
Hepatitis C (HCV): Percutaneous exposure, intravenous drug use/needle sharing.
Sonographic Appearance:
Acute Hepatitis: Liver parenchyma may appear completely normal or diffusely hypoechoic with prominent, bright portal triad walls ("starry sky" appearance), accompanied by gallbladder wall thickening without a positive Murphy's sign.
Chronic Hepatitis: Increased parenchymal echogenicity with a coarse echo texture.
Clinical Features: Acute presentation includes jaundice, fever, chills, nausea, vomiting, right upper quadrant pain, hepatomegaly, and marked LFT elevation. Untreated chronic disease progresses to portal hypertension and cirrhosis.
Pyogenic (Bacterial) Abscess:
Most common form of liver abscess; typically polymicrobial.
Clinical Presentation: High fever, leukocytosis, right upper quadrant pain, and elevated serum LFTs.
Sonographic Findings: Solitary or multiple heterogeneous, complex masses (most commonly in the right lobe) with irregular walls, acoustic enhancement, absent internal blood flow on Color Doppler, surrounding marginal hypervascularity, and bright echogenic foci demonstrating dirty acoustic shadowing from internal gas-producing bacteria.
Amebic (Parasitic) Abscess:
Infection caused by Entamoeba histolytica, acquired through ingestion of contaminated water or food.
Anatomical Location: Subcapsular region of the peripheral right hepatic lobe.
Sonographic Findings: Round or oval mass; early stages appear echogenic prior to necrosis, progressing to a hypoechoic, complex mass containing low-level internal echoes.
Hydatid / Echinococcal Cyst:
Parasitic infection caused by the tapeworm Echinococcus granulosus, endemic to sheep-raising regions.
Sonographic Signs: Anechoic simple or complex cyst containing daughter cysts ("honeycomb pattern"), detached endocyst membranes ("water lily sign"), internal coiled structures ("ball of wool sign"), layered inflammatory debris ("hydatid sand"), and a double-layered wall ("double line sign").
Schistosomiasis:
Parasitic infection endemic to tropical areas, caused by blood flukes acquired via skin contact with infested fresh water.
Pathophysiology: Ova migrate to portal venules, triggering periportal fibrosis.
Sonographic Findings: Dense, focal fibrous thickening of portal venule walls producing a distinctive cross-sectional pattern ("turtle back" appearance), severe portal hypertension, splenomegaly, portosystemic varices, and ascites.
Fungal Candidiasis:
Opportunistic fungal infection occurring in immunocompromised patients (e.g., undergoing active chemotherapy).
Microabscess Manifestations: Classic "wheel-within-wheel" or "bull's-eye" appearance characterized by a peripheral hypoechoic halo surrounding an echogenic central zone with a central spot of necrosis. Late-stage healed lesions convert into dense calcified foci.
Granulomatous Disease (HIV-AIDS):
Chronic inflammatory response to opportunistic infections in HIV-AIDS patients resulting in hepatic granulomas.
Sonographic Findings: Small, dense parenchymal calcifications demonstrating sharp posterior acoustic shadowing.
Hepatic Hematoma:
Hemorrhagic collection caused by blunt abdominal trauma, post-biopsy complications, or spontaneous rupture of a hypervascular neoplasm.
Sonographic Evolution: Hyperacute/fresh blood appears hyperechoic; over time, the collection liquefies and degrades, becoming complex, heterogeneous, and progressively hypoechoic/anechoic.
BENIGN LIVER NEOPLASMS AND LESIONS
Simple Hepatic Cyst:
Congenital fluid-filled parenchymal lesion.
Sonographic Criteria: Anechoic lumen, smooth thin walls, sharp posterior acoustic enhancement, well-defined rounded borders, and complete absence of internal vascularity. Superimposed internal hemorrhage or infection introduces internal debris and low-level echoes.
Autosomal Dominant Polycystic Kidney Disease (ADPKD):
Hereditary disorder presenting with widespread polycystic replacement of renal parenchyma, frequently accompanied by numerous hepatic cysts of variable dimensions.
Cavernous Hemangioma:
Most common benign vascular neoplasm of the liver.
Predilection Site: Posterior segment of the right hepatic lobe, frequently situated directly beneath the capsule.
Sonographic Findings: Homogeneous, well-circumscribed, highly echogenic, round lesion measuring under ; contains micro-vascular channels that lack detectable color Doppler flow. Larger lesions can exhibit internal heterogeneity.
CEUS Features: Peripheral nodular hyper-enhancement during the arterial phase, undergoing centripetal (outer-to-inner) fill-in, with complete sustained enhancement during delayed venous phases matching normal background liver parenchyma.
Focal Nodular Hyperplasia (FNH):
Second most common benign hepatic lesion; composed of hepatocytes, Kupffer cells, bile ducts, and fibrous stroma.
Sonographic Appearance: "Stealth lesion" that appears well-circumscribed and isoechoic to adjacent liver tissue, characterized by a central stellate scar.
Doppler & CEUS Patterns: Color Doppler displays a spoke-wheel vascular architecture with central arterial feeding vessels. CEUS displays rapid centrifugal (inner-to-outer) hyper-enhancement with a tortuous feeding artery, maintaining sustained iso-enhancement into the delayed phase.
Hepatic Adenoma:
Benign liver lesion composed exclusively of hepatocytes; contains no bile ducts or Kupffer cells; carries a high risk of spontaneous hemorrhage, intraperitoneal rupture, and malignant transformation.
Risk Factors: Females taking oral contraceptives, individuals using anabolic steroids, and patients with Type 1 Glycogen Storage Disease.
Sonographic Appearance: Well-defined mass with a hypoechoic peripheral rim/halo, demonstrating internal central and peripheral vascular flow.
CEUS Features: Peripheral hyper-enhancement in early arterial phase with rapid centripetal filling, progressing to sustained enhancement or late weak wash-out.
Infantile Hemangioendothelioma:
Most common benign vascular liver tumor in neonates and infants under of age.
Sonographic Findings: Single or multiple complex masses containing fine linear calcifications, enlarged vascular channels, arterio-venous (AV) shunting, expanded feeding hepatic arteries, and dilated draining hepatic veins. Low resistive index (RI) flow is observed on Color Doppler.
Clinical Complications: Large vascular shunts can precipitate high-output congestive heart failure or trigger Kasabach-Merritt syndrome (consumptive coagulopathy characterized by severe thrombocytopenia and massive hemorrhage).
Mesenchymal Hamartoma:
Second most common benign hepatic tumor found in pediatric populations (typically under old).
Sonographic Findings: Large, avascular mass containing complex multilocular cystic spaces separated by thick internal septations, typically located in the right lobe. Highly favorable prognosis following complete surgical resection.
MALIGNANT LIVER NEOPLASMS
Hepatocellular Carcinoma (HCC):
Most common primary malignant liver neoplasm in adults.
Etiologies: Underlying cirrhosis (most frequent cause) and chronic hepatitis B or C viral infection.
Diagnostic Serum Marker: Marked elevation of Alpha-Fetoprotein (AFP), alongside raised AST, ALT, and ALP.
Sonographic Presentation:
Focal Form: Hypoechoic mass surrounded by a hypoechoic halo; larger lesions become complex, heterogeneous, and display dysmorphic internal vascularity.
Diffuse Form: Infiltrative, diffusely heterogeneous liver parenchyma throughout.
Vascular Invasion: High propensity to invade portal veins or hepatic veins, forming a malignant tumor thrombus that exhibits internal arterial flow signals on Doppler.
CEUS Features: Intense arterial phase hyper-enhancement followed by characteristic slow, weak washout.
Hemangiosarcoma (Angiosarcoma):
Rare, highly aggressive primary hepatic malignancy originating from the endothelial lining of hepatic blood vessels.
Hepatoblastoma:
Most common primary malignant hepatic tumor in infants and young children under of age.
Diagnostic Marker: Extremely high levels of serum Alpha-Fetoprotein (AFP).
Hepatic Metastases:
Most common overall malignant neoplasm found within the liver.
Primary Origin Sites: Gastrointestinal tract, breast, and lungs.
Sonographic Presentation: Classically presents as multiple target or "bull's-eye" lesions with hypoechoic halos, though lesions may present as solitary masses or diffuse parenchymal infiltration. Serum AFP levels are typically normal unless the primary site produces it.
PANCREAS ANATOMY, PHYSIOLOGY, AND ANOMALIES
Anatomy and Relational Boundaries:
Retroperitoneal, non-encapsulated organ situated transversely across the posterior abdominal wall.
Regions: Head, uncinate process, neck, body, and tail.
Peripancreatic Vascular Landmarks:
Splenic Vein: Courses along the posterior border of the pancreatic body and tail in the transverse plane.
Superior Mesenteric Vein (SMV): Courses posterior to the neck of the pancreas and anterior to the uncinate process in the sagittal plane.
Gastroduodenal Artery (GDA): Anterolateral boundary of the pancreatic head.
Common Bile Duct (CBD): Posterolateral boundary of the pancreatic head.
Additional Vascular Borders: Superior Mesenteric Artery (SMA), Abdominal Aorta, IVC, and Portal Confluence.
Adjacent Organ Relationships: C-loop of the duodenum (encircles the head), Stomach (anterior to body/tail), and Spleen (bordering the tail).
Ductal System:
Main Pancreatic Duct (Duct of Wirsung): Extends from tail to head, joining the distal CBD at the Ampulla of Vater (major duodenal papilla), regulated by the Sphincter of Oddi.
Accessory Pancreatic Duct (Duct of Santorini): Drains the superior head independently into the minor duodenal papilla.
Pancreatic Physiology:
Exocrine Function (Acinar Cells):
Amylase: Enzyme responsible for breaking down complex carbohydrates.
Lipase: Enzyme responsible for breaking down fats; remains elevated longer in serum during acute inflammatory states.
Cholecystokinin (CCK): Duodenal peptide hormone that triggers gallbladder contraction and pancreatic enzyme release.
Endocrine Function (Islets of Langerhans):
Alpha Cells: Secrete glucagon to convert liver glycogen into circulating glucose.
Beta Cells: Secrete insulin to facilitate cellular uptake of circulating glucose.
Delta Cells: Secrete somatostatin to regulate and suppress production of insulin and glucagon.
Age-Related Sonographic Appearance:
Adult: Isoechoic or hyperechoic relative to the normal liver parenchyma.
Early Childhood: Hypoechoic relative to the liver.
Neonate: Relatively prominent size, hyperechoic compared to the liver parenchyma.
Congenital Anomalies:
Pancreas Divisum: Most common congenital pancreatic anomaly. Results from failure of the dorsal and ventral pancreatic buds to fuse during embryogenesis, causing the bulk of pancreatic secretions to drain via the accessory duct through the minor duodenal papilla.
Annular Pancreas: Ring of ectopic pancreatic head tissue completely encircling the second portion of the duodenum; causes intrinsic duodenal obstruction and is strongly linked to duodenal atresia or stenosis.
Ectopic Pancreatic Tissue: Aberrant, functional pancreatic tissue located elsewhere in the GI tract.
Cystic Fibrosis:
Autosomal recessive genetic disorder causing severe dysfunction of exocrine glands, predominantly affecting Caucasians.
Pathophysiology: Production of thick, inspissated mucus causes obstruction of pancreatic ductules, leading to chronic pancreatitis, glandular atrophy, fibrotic and fatty replacement, and ultimate pancreatic exocrine insufficiency (manifesting as malabsorption and steatorrhea).
Systemic Findings: Meconium ileus in neonates, microgallbladder, hepatic steatosis, and secondary biliary cirrhosis.
Sonographic Features: Small, diffusely hyperechoic pancreas with parenchymal calcifications and microcystic changes.
PANCREATIC PATHOLOGY AND NEOPLASMS
Acute Pancreatitis:
Acute inflammatory destruction of the pancreatic parenchyma (focal disease most commonly involves the head).
Etiologies: Chronic alcoholism, choledocholithiasis, abdominal trauma, post-surgical trauma, systemic viral infections, drug toxicity, neoplasms, and cystic fibrosis.
Clinical Features: Excruciating epigastric pain radiating to the back (partially relieved by sitting up or leaning forward), nausea, vomiting, fever, and leukocytosis.
Laboratory Findings: Rapid elevation of serum amylase (elevates first), alongside elevated serum lipase (more specific and remains elevated longer).
Sonographic Appearance: Diffusely enlarged, hypoechoic gland with indistinct/irregular margins, focal hypoechoic inflammatory masses, pancreatic duct dilation, gallstones, and peripancreatic fluid collections extending into the anterior pararenal space.
Complications: Pancreatic pseudocyst formation, phlegmon, abscess, acute hemorrhage, SMV/MPV thrombosis, extrahepatic biliary obstruction, and left-sided pleural effusion.
Chronic Pancreatitis:
Recurrent inflammatory episodes causing permanent parenchymal destruction, progressive irreversible fibrosis, glandular atrophy, and loss of endocrine/exocrine function.
Predominant Etiology: Chronic alcohol abuse.
Sonographic Appearance: Heterogeneous, hyperechoic, shrunken gland with coarse ductal wall calcifications, prominent pancreatic duct dilation, and irregular outer contours.
Complications: Pseudocysts (most commonly situated within the lesser sac between the stomach and pancreas), biliary ductal dilatation, and secondary pancreatic carcinoma.
Pancreatic Adenocarcinoma:
Most common primary pancreatic malignancy; arises from exocrine ductal epithelial cells; displays a male predominance.
Typical Location: Head of the pancreas ( of cases).
Clinical Sign: Distal CBD obstruction leading to double duct sign, painless jaundice, and a Courvoisier Gallbladder.
Sonographic Appearance: Hypoechoic, poorly defined focal mass within the head, causing obstruction of the pancreatic duct () and common bile duct.
Surgical Treatment: Pancreaticoduodenectomy (Whipple procedure).
Pancreatic Endocrine / Islet Cell Tumors:
Neoplasms originating from the Islets of Langerhans; can be functional or non-functional, benign or malignant.
Insulinoma: Most common functional islet cell tumor; usually solitary, small, and benign. Triggers clinical hypoglycemia.
Gastrinoma: Second most common functional islet cell tumor; are malignant and frequently multiple. Causes hypersecretion of gastric acid, leading to severe recurrent peptic ulcer disease (Zollinger-Ellison syndrome).
Cystic Pancreatic Neoplasms (Female Predominance):
Serous Cystadenoma (Microcystic): Benign, multiloculated lesion composed of many small cysts under .
Mucinous Cystadenoma (Macrocystic): Benign lesion composed of larger mucin-filled cysts (), carrying significant malignant potential.
Mucinous Cystadenocarcinoma: Malignant mucin-producing tumor; situated primarily in the pancreatic body and tail.
Genetic Syndromes with Pancreatic Involvement:
Von Hippel-Lindau Disease: Development of pancreatic cysts and solid neuroendocrine tumors, alongside bilateral renal cysts and renal cell carcinomas.
Autosomal Dominant Polycystic Kidney Disease (ADPKD): Pancreatic cysts observed in approximately of affected patients.
GALLBLADDER AND BILIARY TREE ANATOMY AND PHYSIOLOGY
Gallbladder Anatomy and Wall Layers:
Anatomical Divisions: Neck, body, and fundus.
Histological Layers (Inner to Outer): Epithelial mucosa, muscularis, subserosa, and serosa.
Normal Gallbladder Wall Thickness: Less than .
Biliary Tree Anatomy and Dimensions:
Common Hepatic Duct (CHD): Formed by the confluence of the Right and Left Hepatic Ducts.
Cystic Duct: Connects the gallbladder neck to the CHD; contains mucosal folds called the Spiral Valves of Heister that prevent kinking, overdistention, or collapse during pressure shifts.
Common Bile Duct (CBD): Formed by the junction of the cystic duct and CHD. Extends inferiorly to join the main pancreatic duct at the Ampulla of Vater, controlled by the Sphincter of Oddi.
Normal Duct Diameter: CHD/CBD diameter is normally under (measurements up to can be acceptable post-cholecystectomy or in elderly individuals).
Blood Supply: Cystic artery, which typically branches from the Right Hepatic Artery (RHA) or less commonly from the Gastroduodenal Artery (GDA).
Biliary Physiology:
Ingestion of fatty foods triggers the release of Cholecystokinin (CCK) from the duodenal mucosa.
CCK causes gallbladder contraction and simultaneous relaxation of the Sphincter of Oddi, releasing stored, concentrated bile into the duodenum to emulsify dietary fats.
Laboratory Parameters:
White Blood Cell (WBC): Marked elevation signifies acute infectious or inflammatory processes (cholecystitis, cholangitis).
Alkaline Phosphatase (ALP): Sensitive marker for biliary obstruction.
ALT, AST, LDH: Mildly elevated during acute biliary tree obstruction.
Anatomical Variants:
Hartman's Pouch: An outpouching or sacculation of the gallbladder neck; common site for gallstone impaction.
Junctional Fold: A structural fold situated at the junction between the neck and body.
Phrygian Cap: Most common anatomical variant, where the fundus folds back over the body.
Congenital Biliary Anomalies:
Septated Gallbladder: Internal division into multiple compartments by thin fibrous septa; predisposes to bile stasis and gallstone formation.
Agenesis & Duplication: Complete failure of development (agenesis) or double gallbladder formation (partial or complete duplication).
Intrahepatic Gallbladder: Complete parenchymal encapsulation of the gallbladder within the liver (precludes standard laparoscopic removal).
Choledochal Cyst Type I: Congenital cystic dilatation of the extrahepatic common bile duct; presents as a large cystic structure in the porta hepatis separate from the gallbladder.
Choledochal Cyst Type V (Caroli Disease): Congenital saccular dilation of intrahepatic bile ducts; manifests as multiple intrahepatic cystic structures communicating directly with the biliary tree. Strongly associated with congenital hepatic fibrosis and ARPKD.
Biliary Atresia: Congenital obliteration or aplasia of extrahepatic and central intrahepatic bile ducts; most common indication for liver transplantation in pediatric patients. Presents in neonates (2–4 weeks) with jaundice and failure to thrive; early Kasai portoenterostomy required before 2 months of age. Associated with polysplenia. Sonographic findings: GB Ghost Triad (microgallbladder under , indistinct wall, irregular contour) and Triangular Cord Sign (echogenic tubular fibrous mass anterior to the portal vein bifurcation).
GALLBLADDER AND BILIARY TREE PATHOLOGY
Cholelithiasis:
Presence of gallstones within the gallbladder lumen.
Clinical Features: Epigastric or right upper quadrant postprandial pain radiating to the right shoulder blade, accompanied by nausea and vomiting.
Sonographic Criteria: Highly echogenic focus, acoustic shadowing, gravity-dependent movement upon repositioning into LLD, and the WES Sign (Wall-Echo-Shadow) seen when a shrunken gallbladder is packed full of stones.
Choledocholithiasis:
Presence of gallstones within the extrahepatic bile ducts (most commonly impacted in the distal CBD).
Sonographic Features: Dilated proximal duct containing an echogenic intraductal focus with acoustic shadowing.
Biliary System Dilatation:
Intrahepatic Biliary Dilatation: Duct diameter exceeds ; visualizes as branched anechoic tubular structures displaying a stellate pattern converging toward the porta hepatis. Causes include Primary Sclerosing Cholangitis, liver neoplasms, Caroli disease, and proximal bile duct strictures.
Extrahepatic Biliary Dilatation: Extrahepatic duct diameter exceeds . Typically results from distal obstructions (e.g., choledocholithiasis, pancreatic head mass). Produces the "Shotgun Sign" or "Parallel Tube Sign", where the dilated duct matches or exceeds the diameter of the adjacent portal vein in the porta hepatis.
Mirizzi Syndrome:
Extrinsic obstruction of the Common Hepatic Duct (CHD) caused by an impacted stone lodged within the cystic duct or gallbladder neck, triggering severe surrounding inflammation.
Gallbladder Sludge (Inspissated Bile):
Non-shadowing, low-level internal echoes layering in the dependent portion of the gallbladder lumen with a fluid-fluid interface.
Hepatization of the Gallbladder: Gallbladder completely filled with dense sludge, rendering its lumen isoechoic to liver parenchyma.
Tumefactive Sludge: Non-layering sludge that mimics a solid polypoid mass; differentiated by lack of internal vascularity on Doppler and normal underlying wall thickness.
Sludge Balls: Mobile, rounded, echogenic masses of sludge that do not shadow.
Hydrops of the Gallbladder (Mucocele):
Marked, non-inflammatory distention of the gallbladder lumen due to long-standing cystic duct obstruction, filled with clear mucoid fluid. Measures in AP diameter with a thin, stretched wall.
Courvoisier Gallbladder:
Marked enlargement and distention of a non-tender, palpable gallbladder caused by an extrinsic malignant obstruction of the distal CBD (typically pancreatic head adenocarcinoma); negative Murphy's sign (-MS).
Acute Cholecystitis:
Acute wall inflammation typically triggered by an impacted stone in the cystic duct.
Clinical Features: Severe right upper quadrant pain, positive sonographic Murphy's Sign (+MS), fever, leukocytosis, and elevated serum ALP, AST, and ALT.
Sonographic Criteria: Positive sonographic Murphy's sign, impacted gallstone, wall thickness , pericholecystic fluid collections, and striated gallbladder wall edema.
Complications of Acute Cholecystitis:
Emphysematous Cholecystitis: Infection caused by gas-producing anaerobic bacteria within the gallbladder wall and lumen; surgical emergency. Strong correlation with diabetes mellitus ( of cases). Displays non-gravity-dependent echogenic foci with dirty shadowing and ring-down artifact.
Gangrenous Cholecystitis: Ischemic tissue necrosis of the gallbladder wall. Displays sloughing intraluminal membranes, wall striations, irregular thickening, and a negative Murphy's Sign due to surgical denervation. Predisposes to free wall perforation and abscess formation.
Empyema (Suppurative Cholecystitis): Gallbladder lumen filled with frank purulent exudate (pus); mimics dense sludge sonographically.
Acute Acalculous Cholecystitis:
Gallbladder wall inflammation in the total absence of gallstones; driven by severe ischemia, bile stasis, or opportunistic infections in critically ill or immunocompromised patients.
Chronic Cholecystitis:
Persistent low-grade inflammation resulting from repeated episodes of acute cholecystitis associated with gallstones. Sonography shows a shrunken, contracted gallbladder with a thick, hyperechoic wall containing stones.
Porcelain Gallbladder:
Submucosal calcification of the gallbladder wall secondary to chronic cholecystitis. Highly significant due to an increased incidence of Gallbladder Carcinoma. Visualized as a bright hyperechoic arc with broad posterior acoustic shadowing.
Extrinsic Causes of Wall Thickening: Congestive heart failure, viral hepatitis, acute pancreatitis, hepatic cirrhosis, massive ascites, renal failure, and systemic sepsis.
BILIARY AND GALLBLADDER NEOPLASMS AND OTHER CONDITIONS
Adenomyomatosis:
Hyperplastic change characterized by excessive proliferation of mucosal epithelium invaginating into a thickened muscular layer, forming Rokitansky-Aschoff Sinuses.
Sonographic Findings: Intramural diverticula containing cholesterol crystals that produce classic V-shaped comet-tail artifacts or twinkling artifacts on Color Doppler. May present as focal thickening at the fundus or annular thickening producing an hourglass gallbladder shape.
Cholesterolosis:
Lipid deposition within the lamina propria of the gallbladder wall.
Diffuse Form: "Strawberry Gallbladder" (gross anatomical appearance of mucosa covered in yellow lipid dots).
Focal Form: Cholesterol Polyps.
Gallbladder Polyps:
Non-mobile, non-shadowing intraluminal projections attached to the mucosa.
Histological Subtypes: Cholesterol polyps (most common, non-neoplastic), Inflammatory polyps (non-neoplastic), and Adenomatous polyps (benign neoplasms carrying malignant potential).
Size Significance: Polyps measuring \n\ge 1\text{ cm} possess high malignant potential and warrant surgical resection.
Gallbladder Carcinoma:
Primary adenocarcinoma of the gallbladder; predominantly affects elderly females.
Risk Factors: Chronic cholecystitis, long-standing cholelithiasis, porcelain gallbladder, rapidly growing polyps, and Primary Sclerosing Cholangitis.
Sonographic Features: Irregular, asymmetrical wall thickening, a distinct polypoid mass with adjacent wall thickening (), complete replacement of the gallbladder lumen by a solid mass, direct encasement of gallstones, or loss of the normal tissue boundary between the gallbladder and liver.
Cholangiocarcinoma:
Primary adenocarcinoma arising from ductal epithelium of the biliary tree.
Sonographic Signs: Regional intrahepatic or extrahepatic biliary dilatation, irregular hypovascular intraductal mass, ductal wall thickening, vascular invasion, and regional lymphadenopathy.
Klatskin Tumor: Specific hilar cholangiocarcinoma located at the confluence of the Right and Left Hepatic Ducts. Sonography shows non-union of dilated right and left intrahepatic ducts at the liver hilum.
Cholangitis:
Inflammation of the bile duct walls, typically secondary to bacterial infection superimposed on biliary obstruction. Predisposes to biliary cirrhosis and cholangiocarcinoma.
Primary Sclerosing Cholangitis (PSC):
Fibrosing inflammatory condition causing progressive destruction and stricturing of intrahepatic and extrahepatic bile ducts.
Disease Association: Strongly linked to Inflammatory Bowel Disease (specifically Crohn's Disease and Ulcerative Colitis).
Pneumobilia:
Presence of air/gas within the biliary tree.
Causes: Previous biliary interventions (biliary stent placement, ERCP), surgical biliary-enteric fistulas, or severe gas-forming infections.
Sonographic Appearance: Highly echogenic linear structures within bile ducts displaying dirty acoustic shadowing or ring-down artifacts.
Cholestatic Pruritus:
Severe cutaneous itching secondary to systemic accumulation of bile acids; associated with Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis, and Cholangiocarcinoma.
Interventional Biliary Modalities:
Endoscopic Retrograde Cholangiopancreatography (ERCP): Fluoroscopic endoscopic procedure used for therapeutic interventions (e.g., stone extraction, stenting); carries a risk of introducing ascending bacterial infection causing cholangitis.
Magnetic Resonance Cholangiopancreatography (MRCP): Non-invasive diagnostic cross-sectional MR imaging of the biliary and pancreatic ductal systems.